Lawrence J, Qiu J, Bai S, Hung HJ. Difference in restricted mean survival time: small sample distribution and asymptotic relative efficiency. Stat Biopharm Res. 2019;1161-66.
Horiguchi M, Uno H. On permutation tests for comparing restricted mean survival time with small sample from randomized trials. Stat Med. 2020;39:2655-2670.
Green S, Benedetti J, Smith A, et al. Clinical Trials in Oncology. 3rd ed. CRC Press; 2016:73-77.
Chiumente M, Mengato D, Messori A. Tisagenlecleucel in non-Hodgkin lymphoma: the restricted mean survival time as a tool for estimating progression-free life expectancy better than the median. Acta Haematol. 2020;143:598-599.
Klein JP, Moeschberger ML. Survival Analysis: Techniques for Censored and Truncated Data. 2nd ed. Springer-Verlag; 2003:118.